Generally. Subject to the provisions of this Article 5, each Holder may, at its option, convert such Holder’s Notes into Conversion Consideration.
Appears in 208 contracts
Sources: Indenture (Bold Eagle Acquisition Corp.), Indenture (Bold Eagle Acquisition Corp.), Indenture (Halozyme Therapeutics, Inc.)
Generally. Subject to the provisions of this Article 5, each Holder may, at its option, convert Convert such Holder’s Notes into Conversion Consideration.
Appears in 54 contracts
Sources: First Supplemental Indenture (Viking Therapeutics, Inc.), Indenture (Voyager Technologies, Inc./Tx), Indenture (BKV Corp)
Generally. Subject to the provisions of this Article Article 5, each Holder may, at its option, convert such Holder’s Notes into Conversion Consideration.
Appears in 5 contracts
Sources: Indenture (Ultra Clean Holdings, Inc.), Indenture (ADTRAN Holdings, Inc.), Indenture (Biora Therapeutics, Inc.)
Generally. Subject to the provisions of this Article Article 5, each Holder may, at its option, convert Convert such Holder’s Notes into Conversion Consideration.
Appears in 3 contracts
Sources: First Supplemental Indenture (Zenas BioPharma, Inc.), Indenture (Ani Pharmaceuticals Inc), First Supplemental Indenture (AeroVironment Inc)
Generally. Subject to the provisions of this Article 5, including Section 5.10, each Holder may, at its option, convert such Holder’s Notes into Conversion Consideration.
Appears in 1 contract
Sources: Indenture (Mitek Systems Inc)
Generally. Subject to the provisions of this Article 5, each Holder may, at its option, convert such Holder’s Notes into the Conversion Consideration.
Appears in 1 contract
Generally. Subject to the provisions of this Article 5, each Holder may, at its option, convert such Holder’s Notes into Conversion Consideration..
Appears in 1 contract
Sources: Indenture (Inotiv, Inc.)